Abeona Therapeutics
ABEO
ABEO
65 hedge funds and large institutions have $170M invested in Abeona Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
4.06% more ownership
Funds ownership: 66.38% → 70.44% (+4.1%)
7% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 15
6% less capital invested
Capital invested by funds: $182M → $170M (-$11.3M)
Holders
65
Holding in Top 10
3
Calls
$3.58M
Puts
$16K
Top Buyers
| 1 | +$3.63M | |
| 2 | +$2.85M | |
| 3 | +$2.15M | |
| 4 |
Goldman Sachs
New York
|
+$747K |
| 5 |
Jane Street
New York
|
+$659K |
Top Sellers
| 1 | -$1.53M | |
| 2 | -$1.03M | |
| 3 | -$572K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$374K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$279K |